vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and CVR PARTNERS, LP (UAN). Click either name above to swap in a different company.
CVR PARTNERS, LP is the larger business by last-quarter revenue ($131.1M vs $77.6M, roughly 1.7× Bioceres Crop Solutions Corp.). CVR PARTNERS, LP runs the higher net margin — -7.8% vs -9.6%, a 1.8% gap on every dollar of revenue. On growth, CVR PARTNERS, LP posted the faster year-over-year revenue change (-6.1% vs -16.8%). Over the past eight quarters, CVR PARTNERS, LP's revenue compounded faster (1.3% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
CVR Partners, LP is a leading North American producer of nitrogen-based fertilizer products, primarily urea ammonium nitrate (UAN) and ammonia. It serves agricultural, industrial and commercial markets across the U.S. and Canada, delivering cost-effective, high-quality nutrient solutions for crop production and diverse industrial use cases.
BIOX vs UAN — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $131.1M |
| Net Profit | $-7.4M | $-10.3M |
| Gross Margin | 46.8% | 4.4% |
| Operating Margin | 9.3% | -2.2% |
| Net Margin | -9.6% | -7.8% |
| Revenue YoY | -16.8% | -6.1% |
| Net Profit YoY | -20.2% | -156.1% |
| EPS (diluted) | $-0.12 | $-0.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $131.1M | ||
| Q3 25 | $77.6M | $163.5M | ||
| Q2 25 | — | $168.6M | ||
| Q1 25 | $60.6M | $142.9M | ||
| Q4 24 | $98.8M | $139.6M | ||
| Q3 24 | $93.3M | $125.2M | ||
| Q2 24 | — | $132.9M | ||
| Q1 24 | $84.0M | $127.7M |
| Q4 25 | — | $-10.3M | ||
| Q3 25 | $-7.4M | $43.1M | ||
| Q2 25 | — | $38.8M | ||
| Q1 25 | $-1.6M | $27.1M | ||
| Q4 24 | $605.2K | $18.3M | ||
| Q3 24 | $-6.2M | $3.8M | ||
| Q2 24 | — | $26.2M | ||
| Q1 24 | $9.8M | $12.6M |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 46.8% | 37.0% | ||
| Q2 25 | — | 32.4% | ||
| Q1 25 | 39.4% | 29.7% | ||
| Q4 24 | 42.0% | 23.8% | ||
| Q3 24 | 40.2% | 14.7% | ||
| Q2 24 | — | 30.0% | ||
| Q1 24 | 50.8% | 21.4% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | 9.3% | 31.0% | ||
| Q2 25 | — | 27.5% | ||
| Q1 25 | 1.5% | 24.2% | ||
| Q4 24 | 14.5% | 18.4% | ||
| Q3 24 | 2.5% | 8.8% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | 15.7% | 15.7% |
| Q4 25 | — | -7.8% | ||
| Q3 25 | -9.6% | 26.3% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | -2.6% | 19.0% | ||
| Q4 24 | 0.6% | 13.1% | ||
| Q3 24 | -6.6% | 3.0% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | 11.6% | 9.9% |
| Q4 25 | — | $-0.98 | ||
| Q3 25 | $-0.12 | $4.08 | ||
| Q2 25 | — | $3.67 | ||
| Q1 25 | $-0.02 | $2.56 | ||
| Q4 24 | $0.00 | $1.73 | ||
| Q3 24 | $-0.10 | $0.36 | ||
| Q2 24 | — | $2.48 | ||
| Q1 24 | $0.14 | $1.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $69.2M |
| Total DebtLower is stronger | — | $569.1M |
| Stockholders' EquityBook value | $288.3M | — |
| Total Assets | $734.9M | $969.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $69.2M | ||
| Q3 25 | $15.5M | $156.2M | ||
| Q2 25 | — | $114.4M | ||
| Q1 25 | $38.5M | $121.8M | ||
| Q4 24 | $29.2M | $90.9M | ||
| Q3 24 | $32.3M | $110.5M | ||
| Q2 24 | — | $47.5M | ||
| Q1 24 | $16.4M | $64.6M |
| Q4 25 | — | $569.1M | ||
| Q3 25 | — | $569.1M | ||
| Q2 25 | — | $569.2M | ||
| Q1 25 | — | $569.3M | ||
| Q4 24 | — | $568.0M | ||
| Q3 24 | — | $547.7M | ||
| Q2 24 | — | $547.6M | ||
| Q1 24 | — | $547.4M |
| Q4 25 | — | — | ||
| Q3 25 | $288.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $345.0M | — | ||
| Q4 24 | $346.3M | — | ||
| Q3 24 | $346.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $348.5M | — |
| Q4 25 | — | $969.5M | ||
| Q3 25 | $734.9M | $1.0B | ||
| Q2 25 | — | $998.0M | ||
| Q1 25 | $798.2M | $1.0B | ||
| Q4 24 | $835.2M | $1.0B | ||
| Q3 24 | $827.3M | $986.6M | ||
| Q2 24 | — | $959.4M | ||
| Q1 24 | $836.1M | $972.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $-21.6M |
| Free Cash FlowOCF − Capex | — | $-45.2M |
| FCF MarginFCF / Revenue | — | -34.5% |
| Capex IntensityCapex / Revenue | — | 18.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $98.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-21.6M | ||
| Q3 25 | $14.4M | $91.7M | ||
| Q2 25 | — | $24.1M | ||
| Q1 25 | $23.3M | $55.4M | ||
| Q4 24 | $-5.4M | $12.8M | ||
| Q3 24 | $5.2M | $86.7M | ||
| Q2 24 | — | $8.6M | ||
| Q1 24 | $-17.4M | $42.4M |
| Q4 25 | — | $-45.2M | ||
| Q3 25 | — | $80.1M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | — | $45.5M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $82.3M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $34.3M |
| Q4 25 | — | -34.5% | ||
| Q3 25 | — | 49.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 31.9% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 26.9% |
| Q4 25 | — | 18.0% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 6.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | -8.85× | 0.70× | ||
| Q3 24 | — | 22.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | -1.78× | 3.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
UAN
| Product UAN | $64.7M | 49% |
| Product Ammonia | $50.5M | 39% |
| Products Other | $8.5M | 7% |
| Product Urea Products | $7.4M | 6% |
